Summarized by Masters of Longevity from Longevity Technology.
Donated human brain research funding progress: a short feature on efforts to extend ex‑vivo perfused brain studies toward longer-term pharmacology and biomarker work.
Key Takeaways
- ARPA-H awarded up to $28.3 million to extend Bexorg's BrainEx platform toward two-week perfusion capability.
- BrainEx circulates fluid through intact donated human brains to enable longitudinal molecular measurements and drug testing.
- Biohaven's BHV-8100 was characterized on BrainEx before human dosing and supported a successful IND filing.
